GSK plans five Phase 3 studies for gynecological cancer ADC from Hansoh
THE SO WHAT
Five Phase 3 trials off a single ADC license is a bet that targeted biologics are now a portfolio engine, not a one-off asset. If you're in oncology or tools, plan for a world where trial throughput and manufacturing capacity — not discovery — are the main constraints.
READ THE SOURCE
MORE FROM THE WIRE
An entrepreneur is transforming a Cold War-era nuclear silo into an underground data center. Look inside.
Data centers are graduating to hardened infrastructure—$10M+ for a decommissioned silo is a bet that compute now warrants bunker-grade protection. If your AI or data strategy assumes commodity colo, you’re underpricing both physical risk and future capacity scarcity.
Inside the $350 million missile silo that could become a data center
When missile silos and abandoned mines are being repriced as $350M data center shells, compute has become a strategic asset class, not a line item. Site selection, security posture, and power access are now board-level questions for any AI-heavy roadmap.
Deep & Emerging Tech‘Disbelief and disappointment’: how Javier Milei’s bribery scandal may have derailed Argentina’s crypto investment
Crypto’s promise as a hedge in unstable economies runs straight into political risk — a $5M bribery scandal and collapsing approval ratings are enough to freeze capital that was lining up to enter. If your web3 thesis depends on “country X instability → adoption,” your real counterparty is local governance, not just user demand.
Deep & Emerging TechTerahertz Waves Spy on a Chip’s Internal Activity
Non-invasive terahertz probing turns chip internals into an observable surface—IP protection and side-channel assumptions on advanced nodes just weakened. If this scales, secure hardware design becomes about shielding and emissions control, not just logic and firmware.